PRINCIPLE COMPONENT EEG ANALYSIS SOFTWARE— 510(k) K951507

Name: FDA 510(k) clearance K951507
Creator: U.S. Food and Drug Administration
Published: 1995-07-14

Substantially Equivalent

Neuroconcepts, Inc.

FDA 510(k) clearance K951507 for PRINCIPLE COMPONENT EEG ANALYSIS SOFTWARE, Substantially Equivalent on 1995-07-14. Applicant: Neuroconcepts, Inc.. Device class: 2.

Clearance details

Applicant: Neuroconcepts, Inc.
Product code: Code GWQ
Device class: Class 2
Regulation: 21 CFR 882.1400
Advisory panel: Neurology
Date received: 1995-04-03
Decision date: 1995-07-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Middleton, WI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GWQ

view all

K261604 — Enobio Dx (3 models)2026-06-13
K260455 — New Wave System2026-03-13
K233403 — Flexset System2024-04-30
K231366 — Neuronaute Plus2023-11-09
K221959 — Q212023-08-31

More clearances from Neuroconcepts, Inc.

view all

K951724 — QUANTITATIVE EEG ANALYSIS SOFTWARE1995-07-14
K905435 — UNIQUANT1991-07-22

Data sourced from openFDA. This site is unofficial and independent of the FDA.